
NEC Baby Formula Lawsuit
Premature and newborn infants fed cow's milk-based formula such as Similac and Enfamil may develop necrotizing enterocolitis (NEC) — a life-threatening intestinal disease. Families of affected infants may be entitled to significant compensation from Abbott and Mead Johnson.
Get A Free Case ReviewATTENTION: PARENTS OF PREMATURE INFANTS
If your premature baby was fed Similac or Enfamil and developed NEC, you could be entitled to SIGNIFICANT compensation!
Consumers Injury Help offers a completely free case review and manages the entire process. Studies show premature infants fed cow's milk-based formula face a significantly higher risk of developing necrotizing enterocolitis. Abbott and Mead Johnson are facing thousands of lawsuits alleging they failed to warn parents and doctors of this risk.
Find Out if You Qualify
SIGNIFICANT Compensation May Be Available
LARGE SETTLEMENT AMOUNT
COULD BE CLAIMED
How do we help YOU?
Thousands of families have filed lawsuits against Abbott (Similac) and Mead Johnson/Reckitt (Enfamil) alleging that these companies knew their cow's milk-based formulas significantly increase NEC risk in premature infants but failed to warn parents and healthcare providers. Several jury verdicts have already awarded hundreds of millions of dollars to affected families.
How does filing a claim work?
- 1. Fill out our simple form. Or call to make your claim immediately.
- 2. Get a FREE case review from our expert partners.
- 3. We fight on your behalf for the highest compensation possible.
- 4. Claim your settlement!
- Remember: you only pay if you get a settlement! Our service is totally RISK FREE.
Research shows premature infants fed cow's milk formula face a dramatically higher NEC risk — yet formula makers failed to warn families.
Multiple peer-reviewed studies have shown that cow's milk-based formula significantly increases the risk of NEC in premature infants compared to breast milk or donor human milk. Abbott Laboratories and Mead Johnson are accused of knowing this risk for decades and choosing profit over the safety of the most vulnerable patients — premature newborns in the NICU.
What Is the NEC Baby Formula Lawsuit About?
Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease that primarily affects premature infants. It causes inflammation and destruction of intestinal tissue and can be fatal. Lawsuits allege that Abbott Laboratories (maker of Similac) and Mead Johnson/Reckitt (maker of Enfamil) failed to warn parents and neonatologiststhat their cow's milk-based formulas significantly increase NEC risk in premature babies.
Scientific evidence linking cow's milk formula to NEC has existed for decades. Despite this, formula manufacturers marketed their products without adequate warnings, leaving families uninformed about the life-threatening risks. Thousands of lawsuits have been filed across the country, and several have already resulted in major jury verdicts for plaintiffs.
Who Qualifies for the NEC Baby Formula Lawsuit?
You may qualify if your premature infant was fed Similac, Enfamil, or another cow's milk-based formula in the NICU and subsequently developed NEC or related complications — especially if the infant required surgery, experienced intestinal perforation, or passed away.
Did cow's milk formula cause your infant's NEC?
Get A Free Case ReviewSigns and Complications of NEC
- Abdominal distension — swelling and tenderness of the belly
- Bloody stools — a warning sign of intestinal damage
- Feeding intolerance — inability to digest formula normally
- Intestinal perforation — holes in the bowel requiring emergency surgery
- Sepsis — life-threatening infection spreading from the gut
- Short bowel syndrome — long-term complications from surgical removal of intestine
- Death — NEC has a mortality rate of 20-30% in premature infants
NEC Lawsuit Timeline
- 2022: First major NEC jury verdict — $495 million awarded against Mead Johnson (later reduced on appeal)
- 2023: Federal MDL consolidation — thousands of cases centralized for coordinated pretrial proceedings
- 2024: Illinois jury awards $60 million; more bellwether trials scheduled
- 2025-2026: Additional bellwether trials underway; settlement negotiations ongoing
- Act now: Statutes of limitations vary by state — waiting too long could bar your claim
